Key MHLW Panel Backs Iron Replacement Therapy Ferinject, No Vyvanse Review

February 1, 2019
A key health ministry panel gave its thumbs-up to Zeria Pharmaceutical’s iron deficiency treatment ferric carboxymaltose on January 31. If all goes without a hitch, the drug, known as Ferinject overseas, is expected to win official approval as early as...read more